ResearcherMiyagi Prefectural Hospital OrganizationActive in the last 2 years
Makoto Abue
Matched on ORCID iD 0000-0002-1469-6841; OpenAlex author ID A5016046209. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort Study. Co-author DOI 10.3390/cancers17122006↗
- [A case of anaplastic pancreatic cancer with osteoclast-like giant cells during follow-up of a branch-duct pancreatic intraductal papillary mucinous tumor]. First author DOI 10.11405/nisshoshi.119.961↗
- The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality… Last author DOI 10.1089/pancan.2021.0005↗
- CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1016/j.pan.2020.01.013↗
- Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen spec… Co-author DOI 10.3892/ijo.2018.4258↗
- Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Co-author DOI 10.3892/ijo.2014.2743↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ikuro Sato · 5 shared papers, 2015–2025 · strength 0.61
- Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
- Paper [A case of anaplastic pancreatic cancer with osteoclast-like giant cells during follow-up of a branch-duct pancreatic i… DOI 10.11405/nisshoshi.119.961↗
- Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
- Keiichi Tamai · 4 shared papers, 2015–2025 · strength 0.46
- Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
- Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
- Paper Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production… DOI 10.3892/ijo.2018.4258↗
- Kensuke Ota · 2 shared papers, 2022–2025 · strength 0.39
- Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
- Paper [A case of anaplastic pancreatic cancer with osteoclast-like giant cells during follow-up of a branch-duct pancreatic i… DOI 10.11405/nisshoshi.119.961↗
- Yasuko Murakawa · 1 shared paper, 2021 · strength 0.22
- Kazuo Sugamura · 2 shared papers, 2015–2020 · strength 0.14
- Misa Yokoyama · 2 shared papers, 2015–2018 · strength 0.12
- Kennichi Satoh · 2 shared papers, 2015–2018 · strength 0.12
- Yuuri Hatsuzawa · 1 shared paper, 2020 · strength 0.10
- Masamichi Mizuma · 1 shared paper, 2020 · strength 0.10
- Michiaki Unno · 1 shared paper, 2020 · strength 0.10
- Shin Hamada · 1 shared paper, 2015 · strength 0.05
- Tooru Shimosegawa · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.